10 Stocks Breaking Records While Wall Street Bleeds

3. Qiagen NV (NYSE:QGEN)

Qiagen soared to a four-year high on Tuesday, as investors loaded portfolios ahead of the results of its earnings performance in the full year and fourth quarter of 2025.

At intra-day trading, the stock jumped to its highest price of $57.81 before trimming a few cents to end the day just up by 16.57 percent at $55.45 apiece.

In a statement, Qiagen NV (NYSE:QGEN) said that it would release the results of its financial and operating highlights after market close on Wednesday, February 4. A conference call will be held before market open on Thursday, February 5, to discuss the results.

In its last earnings call last year, Qiagen NV (NYSE:QGEN) announced expectations of 4 to 5 percent growth in net sales for full-year 2025, including about 5 to 6 percent constant exchange rates (CER) growth in the core business, excluding revenues from discontinued products.

Based on what it deems a strong 2025, it is targeting to report adjusted diluted earnings per share of $2.38 CER, or a 9 percent CER growth from $2.18 in 2024.

Qiagen NV (NYSE:QGEN) noted that the outlook reflects continued macroeconomic challenges, including headwinds from import tariffs and the US government shutdown.

For the fourth quarter of 2025 alone, net sales are expected to remain steady at CER rates, compared to $521 million in the same period a year earlier.

Adjusted diluted EPS is expected to be at $0.60 CER compared to $0.61 in the same comparable period.